XML 25 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Aug. 31, 2020   40,767,708        
Beginning balance at Aug. 31, 2020 $ 896,375 $ 408 $ 939,067 $ (636,956) $ 633,149 $ (39,293)
Beginning balance, treasury stock (in shares) at Aug. 31, 2020       2,737,456    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 399,590       399,590  
Other comprehensive income (loss) 331         331
Common stock issued for employee stock plans (in shares)   360,877   318    
Common stock issued for employee stock plans 64,073 $ 4 64,173 $ (104)    
Vesting of restricted stock (in shares)   34,607   12,614    
Vesting of restricted stock $ (4,155)     $ (4,155)    
Repurchase of common stock (in shares) 797,385     797,385    
Repurchases of common stock $ (264,702)     $ (264,702)    
Stock-based compensation expense 45,065   45,065      
Dividends declared (120,224)       (120,224)  
Balance, end of period (in shares) at Aug. 31, 2021   41,163,192        
Ending balance at Aug. 31, 2021 1,016,353 $ 412 1,048,305 $ (905,917) 912,515 (38,962)
Ending balance, treasury stock (in shares) at Aug. 31, 2021       3,547,773    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 396,917       396,917  
Other comprehensive income (loss) (69,421)         (69,421)
Common stock issued for employee stock plans (in shares)   450,527   260    
Common stock issued for employee stock plans 85,919 $ 5 86,042 $ (128)    
Vesting of restricted stock (in shares)   39,499   14,229    
Vesting of restricted stock $ (6,031)     $ (6,031)    
Repurchase of common stock (in shares) 46,200     46,200    
Repurchases of common stock $ (18,639)     $ (18,639)    
Stock-based compensation expense 56,003   56,003      
Dividends declared $ (129,693)       (129,693)  
Balance, end of period (in shares) at Aug. 31, 2022 38,044,756 41,653,218        
Ending balance at Aug. 31, 2022 $ 1,331,408 $ 417 1,190,350 $ (930,715) 1,179,739 (108,383)
Ending balance, treasury stock (in shares) at Aug. 31, 2022 3,608,462     3,608,462    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 468,173       468,173  
Other comprehensive income (loss) 21,242         21,242
Common stock issued for employee stock plans (in shares)   360,375   410    
Common stock issued for employee stock plans 71,840 $ 3 72,003 $ (166)    
Vesting of restricted stock (in shares)   83,035   32,034    
Vesting of restricted stock (13,544) $ 1 (1) $ (13,544)    
Excise tax on share repurchases $ (932)     $ (932)    
Repurchase of common stock (in shares) 430,350     430,350    
Repurchases of common stock $ (176,720)     $ (176,720)    
Stock-based compensation expense 62,038   62,038      
Dividends declared (142,816)       (142,816)  
Other $ (759)   (759)      
Balance, end of period (in shares) at Aug. 31, 2023 38,025,372 42,096,628        
Ending balance at Aug. 31, 2023 $ 1,619,930 $ 421 $ 1,323,631 $ (1,122,077) $ 1,505,096 $ (87,141)
Ending balance, treasury stock (in shares) at Aug. 31, 2023 4,071,256     4,071,256